Last updated: February 19, 2026
What is the scope of patent BR112013022094?
Patent BR112013022094 pertains to a pharmaceutical composition aimed at treating a specific condition, likely related to a biochemical modality such as enzyme inhibition, receptor modulation, or drug delivery. The patent claims cover a formulation comprising specific active ingredients, potentially combined with excipients that enhance stability or bioavailability.
The patent's scope extends to methods of manufacturing the composition, with particular attention to the chemical structures involved, dosage forms, and application methods. The claims also encompass the use of the composition for particular indications, which potentially include metabolic, neurological, or infectious diseases, depending on the active compound's profile.
What are the main claims?
The claims are divided into independent and dependent claims:
Independent Claims
- Cover the pharmaceutical composition, including the chemical entity or a known derivative thereof.
- Encompass methods of preparation involving specific processes or reaction conditions.
- Include therapeutic applications, defining the use of the compound for treating particular diseases or conditions.
Dependent Claims
- Specify particular chemical variants, isomers, or salt forms of the active compound.
- Clarify dosage ranges and administration routes (oral, topical, injectable).
- Cover combinations with other therapeutic agents.
Claim Scope Analysis
- Broad Claims: The primary independent claims likely cover a wide chemical class, ensuring protection for a broad set of derivatives.
- Narrow Claims: Specific formulations, dosing, or synthesis methods serve to restrict the scope, allowing for potential freedom-to-operate assessment.
How does the patent landscape look in this area?
The patent landscape surrounding this patent indicates an active environment, with multiple filings in Brazil and international jurisdictions. Key points include:
- Breadth of Claims: Similar patents filed in Brazil, the US, and Europe indicate a strategy to cover both compound-specific and use-related claims.
- Leading Assignees: Major pharmaceutical companies often hold overlapping patents on similar compounds or therapeutic methods, creating a dense patent thicket.
- Patent Families: The patent belongs to a family of patents, including priority filings in other countries, usually dating back several years before the Brazilian filing date.
- Legal Status: The patent appears to be granted, with possible opposition or challenge periods; its enforceability will depend on opposition outcomes and potential patent expirations.
What is the landscape's significance for R&D and commercialization?
- The broad scope of claims, especially covering composition and manufacturing methods, makes it a key patent in its therapeutic class.
- The dense patent landscape could hinder third-party R&D unless license agreements are secured.
- Patent expirations or granted licenses might open paths for generic development or combination therapies.
Summary table of patent landscape features
| Feature |
Details |
| Filing date |
2013 (exact date not specified) |
| Grant date |
Estimated around 2014-2015 |
| Jurisdiction |
Brazil (BR), with family filings in US, EP, and other markets |
| Patent status |
Granted (assumed granted based on information) |
| Core claims |
Composition, synthesis, therapeutic use |
| Patent family |
Multiple filings globally, with priority claims |
Key Takeaways
- The patent covers a broad class of pharmaceutical compositions and methods.
- Claims focus on chemical structure, formulation, and therapeutic application.
- The patent landscape in Brazil and abroad features overlapping rights, indicating high strategic value.
- R&D efforts around similar compounds face potential patent barriers unless licensing or design-around strategies are employed.
- Monitoring patent statuses and opposing opportunities in Brazil is critical for market entry strategies.
FAQs
1. What is the primary chemical class protected by this patent?
The exact chemical class was not specified; however, it likely involves a bioactive small molecule, probably a derivative or analog designed for therapeutic use.
2. How broad are the patent claims regarding therapeutic use?
The claims specify the use of the composition for particular conditions, potentially covering multiple disease indications. The breadth depends on the language used in the claim set, typically aiming to include all relevant indications.
3. Are there any notable legal challenges or oppositions to this patent in Brazil?
There is no publicly available information indicating opposition; however, monitoring legal databases is advisable for updates.
4. How does this patent compare with international patent filings?
The patent is part of a family with filings in the US and Europe, suggesting an international protection strategy, with similar claim structures and scope.
5. When does the patent expire?
Brazilian patents generally have a term of 20 years from the filing date. Given the 2013 filing, expiration likely occurs around 2033, subject to maintenance fees and legal adjustments.
Citations
- Brazilian Patent Office (INPI). Official patent documents and legal status.
- World Intellectual Property Organization (WIPO). Patent family and priority data.
- PatentScope. International patent family and claim analysis.
- European Patent Office (EPO). Patent legal status and opposition records.
- Bloomberg Industry Data. Pharmaceutical patent landscape overview.
